Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo

Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo

Introduction: Overactive bladder (OAB) syndrome has a negative impact on quality of life and prevalence increases with advanced age. Anticholinergics (AC) and beta-3 adrenergic agonists (β3a) are commonly prescribed medications for treatment of OAB. AC medication has been associated with dementia in...

Full description

Bibliographic Details
Main Authors: Rachel A. High, Jill M. Danford, Zhaoyue Shi, Christof Karmonik, Thomas J. Kuehl, Erin T. Bird, Rose Khavari
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Contemporary Clinical Trials Communications
Subjects:
Urinary incontinence
Overactive bladder syndrome
Solifenacin
Mirabegron
Cognitive dysfunction
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865420301058

Similar Items

Similar Items